Continuation of follow-up of DES-exposed cohorts
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN261201000137C
- Awardee
-
The Methodist Hospital Research Institute UEI XJUCJAYJWYV1 Part of The Methodist Hospital
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $457,000
Award facts
- Opportunity
-
- N02CP0101177 Solicitation number
- Contract value 52% obligated
- $882,019.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Houston, TX 77030, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$373,900 | |
| Funding Only Action | -$51,119 | |
| Exercise an Option | $179,004 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $175,914 | |
| Exercise an Option | $172,915 | |
| Exercise an Option | $183,503 | |
| Other Administrative Action | $0 | |
| Original award | $170,683 |
About this award
This is a definitive contract awarded by the National Cancer Institute (NCI), a civilian agency, to The Methodist Hospital Research Institute Division, a subcontract of the parent organization The Methodist Hospital (doing business as Houston Methodist Hospital). The contract, valued at $882,019.00, is for the continuation of follow-up studies on cohorts exposed to diethylstilbestrol (DES), a synthetic estrogen previously used to prevent miscarriage. The contract has no set-aside designation and was awarded on September 30, 2010, with a completion date of September 18, 2015. The Methodist Hospital Research Institute Division has provided research services to federal agencies like the Department of Defense and NIH under various prime and subcontract awards, primarily focused on biomedical research across therapeutic areas including cancer, neurological disorders, infectious diseases, and cardiovascular diseases.
Quick answers
Who was awarded contract HHSN261201000137C?
HHSN261201000137C was awarded to The Methodist Hospital Research Institute by National Cancer Institute (National Institutes of Health) on September 30, 2010.
How much is contract HHSN261201000137C worth?
The government has obligated $457,000 on HHSN261201000137C. Its current value, with exercised options, is $882,019.
Was contract HHSN261201000137C competed?
The extent of competition for HHSN261201000137C was full and open competition. The government received 5 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award